S'abonner

Elevated Body Mass Index and Use of Coronary Revascularization after Cardiac Catheterization - 12/08/11

Doi : 10.1016/j.amjmed.2008.09.036 
Kathryn M. King, RN, PhD a, , Danielle A. Southern, MSc a, Jacques Cornuz, MD, MPH b, Andrew Maitland, MB, FRCSC, FACS c, Merril L. Knudtson, MD c, William A. Ghali, MD, MPH a
a University of Calgary, Calgary, AB, Canada 
b University Hospital, Lausanne, Switzerland 
c Calgary Health Region, Calgary, AB, Canada 

Requests for reprints should be addressed to Kathryn M. King, RN, PhD, Centre for Health and Policy Studies, Department of Community Health Sciences, University of Calgary, 3330 Hospital Drive NW, Calgary, AB, Canada T2N 4N1

Abstract

Background

Obese persons suffer discrimination in society that may extend to health care use. We investigated whether overweight and obese patients are as likely to undergo coronary reperfusion or revascularization as patients of normal body weight.

Methods

Detailed clinical data were collected for an inception cohort of patients from Alberta, Canada, who underwent cardiac catheterization between April 2001 and March 2004. The patients' likelihood of receiving any revascularization, percutaneous coronary intervention, or coronary artery bypass graft surgery in the year after cardiac catheterization was examined on the basis of body mass index (BMI) grouping. Use of revascularization was examined separately for patients with high- and low-risk coronary disease.

Results

Of 27,460 patients who had BMI data recorded, 24% were of normal weight, 42% were overweight, and 35% were obese. Although overweight and obese patients were more likely to have percutaneous coronary intervention (adjusted hazard ratio [HR]=1.07, 95% confidence interval [CI], 1.01-1.12 and HR 1.08, 95% CI, 1.01-1.13, respectively), obese patients (BMI>30) were less likely to receive coronary artery bypass graft surgery (adjusted HR=0.93, 95% CI, 0.87-1.00). This was primarily because of less use of coronary artery bypass graft surgery for the most obese patients (obesity class III) with low-risk coronary anatomy (adjusted HR=0.61, 95% CI, 0.36-1.02).

Conclusion

The pattern of use of revascularization procedures after cardiac catheterization differs somewhat across BMI subgroups. These differences might be clinically appropriate, but they warrant further exploration.

Le texte complet de cet article est disponible en PDF.

Keywords : Access, Coronary revascularization, Obesity


Plan


 Funding: The Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease was initially funded with a grant from the W. Garfield Weston Foundation. The ongoing operation of this project has been made possible by operating grants from the Heart and Stroke Foundation of Alberta, Northwest Territories, and Nunavut, and the Canadian Institutes of Health Research, as well as support from the Canadian Cardiovascular Outcomes Research Team, a Canadian Institutes of Health Research-funded team grant initiative. The initiative also has received contributions from Alberta Health and Wellness, Merck Frosst Canada Inc, Monsanto Canada Inc-Searle, Eli Lilly Canada Inc, Guidant Corporation, Boston Scientific Ltd, Hoffmann-La Roche Ltd, and Johnson & Johnson Inc—Cordis. Dr King holds a Health Scholar Award from the Alberta Heritage Foundation for Medical Research. Dr Knudtson receives partial support from the Libin Trust Fund. Dr Ghali is supported by a Government of Canada Research Chair in Health Services Research and by a Senior Health Scholar Award from the Alberta Heritage Foundation for Medical Research.
 Conflict of Interest: None of the authors have any conflicts of interest associated with the work presented in this article.
 Authorship: All authors had access to the data and played a role in writing this article.


© 2009  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 122 - N° 3

P. 273-280 - mars 2009 Retour au numéro
Article précédent Article précédent
  • B-Type Natriuretic Peptides for the Evaluation of Exercise Intolerance
  • Christian Mueller, Micha T. Maeder, Andreas Christ, Tobias Reichlin, Daniel Staub, Markus Noveanu, Tobias Breidthardt, Mihael Potocki, Martin H. Brutsche
| Article suivant Article suivant
  • Staphylococcus Aureus Bacteremia Among Patients with Health Care-associated Fever
  • Martin E. Stryjewski, Zeina A. Kanafani, Vivian H. Chu, Paul A. Pappas, Tina Harding, Laura A. Drew, Daniel K. Benjamin, L. Barth Reller, Benjamin A. Lee, G. Ralph Corey, Vance G. Fowler

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.